CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,874,569 | +22.3% | 362,436 | -0.1% | 0.05% | +30.0% |
| Q2 2023 | $8,074,703 | +68.7% | 362,908 | +64.2% | 0.04% | +53.8% |
| Q1 2023 | $4,787,120 | +69.9% | 221,012 | +59.3% | 0.03% | +62.5% |
| Q4 2022 | $2,817,870 | +33.5% | 138,743 | +68.6% | 0.02% | +14.3% |
| Q3 2022 | $2,110,000 | +18.8% | 82,298 | +10.2% | 0.01% | +27.3% |
| Q2 2022 | $1,776,000 | -42.7% | 74,664 | -45.7% | 0.01% | -26.7% |
| Q1 2022 | $3,098,000 | +225.4% | 137,550 | +186.0% | 0.02% | +200.0% |
| Q4 2021 | $952,000 | +308.6% | 48,101 | +305.9% | 0.01% | +400.0% |
| Q3 2021 | $233,000 | – | 11,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,340,193 | $227,229 | 10.94% |
| Novo Holdings A/S | 3,377,768 | $92,044,178 | 6.80% |
| Parallel Advisors, LLC | 3,723,483 | $101,446,294 | 3.38% |
| TANAKA CAPITAL MANAGEMENT INC | 37,569 | $1,024 | 2.92% |
| S&T BANK/PA | 334,252 | $9,107 | 1.76% |
| Birchview Capital, LP | 50,000 | $1,362,250 | 1.16% |
| Granite Investment Partners, LLC | 798,552 | $21,756,549 | 0.91% |
| FAS Wealth Partners, Inc. | 310,764 | $8,466,766 | 0.90% |
| Clearview Wealth Advisors LLC | 25,258 | $688,155 | 0.85% |
| Bridge City Capital, LLC | 43,485 | $1,184,749 | 0.60% |